Novabay Pharmaceuticals (NBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 15,684 | 6,722 | 5,913 | 1,533 | 0 |
| Gross Profit | 15,684 | 6,722 | 5,913 | 1,533 | N/A |
| Operating Expenses | 12,944 | 15,231 | 11,789 | 7,059 | 3,569 |
| Operating Income | 2,740 | -8,509 | -5,876 | -5,526 | -3,569 |
| Other Income | -36 | 397 | 488 | 240 | 106 |
| Pre-tax Income | 2,704 | -8,112 | -5,388 | -5,286 | -3,463 |
| Income Tax | 7 | 2 | 12 | N/A | N/A |
| Net Income Continuous | 2,697 | -8,114 | -5,400 | -5,286 | -3,463 |
| Net Income | $2,697 | $-8,114 | $-5,400 | $-5,286 | $-3,463 |
| EPS Basic Total Ops | 3,667.66 | -11,614.26 | -18,338.31 | -28,118.74 | -21,700.33 |
| EPS Basic Continuous Ops | 3,679.28 | -11,636.40 | -18,391.44 | -28,269.55 | -21,814.22 |
| EPS Diluted Total Ops | 3,667.66 | -11,614.26 | -18,338.31 | -28,118.74 | -21,700.33 |
| EPS Diluted Continuous Ops | 3,566.11 | -11,636.40 | -18,391.44 | -28,269.55 | -21,814.22 |
| EBITDA(a) | $3,155 | $-8,262 | $-5,939 | $-5,484 | $-3,521 |